Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05082454 · ClinicalTrials.gov registry record

Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)

A clinical trial of Aortic Valve Disease, sponsored by JOTEC.

Active
Registry status
108
Enrollment target
11
Study locations

NCT05082454 is a study of Aortic Valve Disease that is active but no longer recruiting, run by JOTEC. The registered enrollment target is 108 participants, below the 18,610-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 11 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05082454, a study of Aortic Valve Disease, is active but no longer recruiting, sponsored by JOTEC.

ACTIVE NOT RECRUITING
Registry status
108 participants
Enrollment target
11
Study locations

Study Summary

The ASCEND post-market clinical follow-up study is undertaken to evaluate safety and clinical performance of the On-X Ascending Aortic Prosthesis (AAP) used in surgical aortic valve replacement.

Conditions Studied

Interventions

  • DEVICE Open repair

Study Locations (11)

Other

  • Medizinische Hochschule Hannover (MHH) - Hanover
  • University Hospital Magdeburg - Magdeburg
  • Policlinico S. Orsola-Malpighi - Bologna
  • Hospital Germans Trias i Pujol - Badalona
  • Hospital de la Santa Creu i Sant Pau - Barcelona
  • Castle Hill Hospital - Cottingham
  • St Bartholomew's Hospital - London
  • Newcastle Freeman Hospital - Newcastle

Pennsylvania

  • Geisinger Health System - Danville

Texas

  • Baylor College of Medicine - Houston

Virginia

  • VCU Medical Center Main Hospital - Richmond

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2021-10-20
Est. Completion 2029-03-31

Sponsor

JOTEC

1 total trials

What the Registry Record Tells You About NCT05082454

The ClinicalTrials.gov registry entry for NCT05082454 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,610-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The listed sponsor is JOTEC, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which Open repair is the first listed.

NCT05082454 reports 11 study locations spanning 4 distinct geographic areas - top geographies include Other, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT05082454 about?

NCT05082454 is a clinical study titled "Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)". The ASCEND post-market clinical follow-up study is undertaken to evaluate safety and clinical performance of the On-X Ascending Aortic Prosthesis (AAP) used in surgical aortic valve replacement.

What is the current status of trial NCT05082454?

This trial is currently active not recruiting. The enrollment target is 108 participants. The study started on 2021-10-20. Estimated completion is 2029-03-31.

What conditions does trial NCT05082454 study?

This clinical trial studies the following conditions: Aortic Valve Disease.

What interventions are being tested in trial NCT05082454?

The interventions under investigation include: Open repair (DEVICE).

Who is sponsoring clinical trial NCT05082454?

This trial is sponsored by JOTEC, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05082454 being conducted?

This trial has 11 study locations across Pennsylvania, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.